VANGUARD GROUP INC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Travere Therapeutics Inc (TVTX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Travere Therapeutics Inc Common Stock
Symbol: TVTX
Shares outstanding: 87M shares
Disclosed Ownership: 6.74M shares
Ownership: 7.75%
Form type: SCHEDULE 13G/A
Date filed: 1/31/2025, 10:09 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	7.75%	6.74M	0	53.8K	Ashley Grim	Head of Global Fund Administration